Skip to main content
. 2012 Jul 1;7(7):710–719. doi: 10.4161/epi.20524

Table 3. Summary of Spearman correlations for pair of genes (promoter methylation) in thyroid samples.

    THYROID CANCER                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RASSF1A
0.56 *
0.41
0.06
0.23
0.48
0.22
-0.11
0
0.08
-0.18
-0.15
0.14
0.33
-0.1
0.08
-0.13
0.24
0.11
0.04
-0.11
-0.06
0.61 *
TSHR
0.63 *
0.6 *
0.52
0.77 *
0.47
0.15
-0.03
0.31
0.21
-0.04
0.04
0.36
-0.07
0.15
-0.18
0.1
0.26
0.1
0.15
-0.23
0.36
0.5 *
CALCA
0.68
0.37
0.45
0.25
0.27
0.34
0.33
0.36
-0.26
-0.1
0.36
0.06
0.04
-0.17
0.09
0.08
-0.21
0.02
-0.24
0.41
0.74 *
0.48
CDH1
0.39
0.41
0.45
0.36
0.23
0.42
0.58
-0.03
0
0.4
-0.03
0.19
0.09
0.15
0.14
-0.18
0.33
-0.18
0.23
0.35
0.23
0.49
TIMP3
0.36
0.26
0.19
0.25
0.22
0.05
-0.04
-0.01
0.29
-0.16
0.21
-0.23
0.18
0.18
-0.1
0.24
-0.16
0.6
0.84 *
0.49
0.66
0.27
TGFβR2
0.34
-0.07
-0.1
0.17
0.03
-0.08
0.06
0.32
-0.14
0.14
-0.27
0.02
0.51
0.06
0
-0.13
0.22
-0.05
-0.14
-0.16
0.1
-0.05
MINT1
-0.01
0.17
0.37
0.29
-0.02
0.05
0.37
0.1
0.43
-0.01
0
0.01
0.22
0.17
0.08
0.1
0.15
0.35
0.34
0.34
0.27
0.07
DCC
0.37
0.25
0.25
-0.01
0.18
0.2
0.17
-0.1
-0.13
0.08
-0.07
-0.09
0.09
-0.1
0.22
0.23
0.01
0.27
0.17
0.22
0.02
0.14
MT1G
0.12
0.22
-0.14
0.15
0.25
0.05
-0.04
-0.2
0.33
0.14
-0.04
0.18
-0.08
-0.07
-0.05
0.03
0.05
0.1
0.02
0.14
-0.09
-0.08
RARβ2
0.25
-0.11
-0.09
0.15
0.15
0.18
-0.08
0.08
0.05
-0.03
0.26
-0.07
-0.07
0.08
-0.01
0.16
0.29
-0.08
-0.35
-0.07
-0.04
-0.09
DAPK
0.07
0.1
0.19
0.18
0.09
0.07
-0.02
-0.06
-0.15
0.27
-0.18
-0.13
-0.19
-0.15
-0.14
-0.04
-0.24
-0.18
-0.09
0.32
-0.04
-0.12
GSTP1
-0.06
-0.13
-0.05
-0.13
0.15
0.08
0.11
0.15
0.17
-0.05
0.12
0.22
0.14
0.09
0.08
0.26
-0.18
-0.09
-0.08
-0.04
0.19
-0.04
p16
0.2
0.21
-0.1
-0.07
0.36
-0.01
-0.18
0.21
-0.04
0.09
0.16
0.04
0.12
0.13
0.21
0.13
-0.03
0.01
-0.1
0.09
-0.1
-0.1
THBS1
0.04
0.16
0.07
0.08
0.15
-0.17
0.03
-0.07
0.03
-0.11
-0.06
0.05
0.11
-0.08
0.16
0.19
0.06
-0.17
-0.16
0.01
-0.17
0.2
S100A2
0.06
-0.04
0.05
-0.1
-0.02
0.18
-0.14
-0.05
0.01
-0.01
-0.02
-0.22
0.06
-0.22
-0.15
-0.15
-0.04
-0.1
-0.04
-0.04
0.25
-0.24
CTNNB1
0.06
0.01
-0.05
0.09
0.03
-0.07
0.1
0.22
0.19
0.21
0
0.22
-0.22
-0.18
-0.04
-0.01
0.1
-0.15
0.24
0.18
-0.18
0.36
hMLH1
-0.07
-0.14
0.1
-0.04
-0.08
-0.03
0
0.1
-0.02
0.09
-0.03
0.1
-0.09
0.05
0.16
-0.17
-0.16
-0.16
0.03
0
0.32
0.01
ATM
0.04
-0.04
0.43
-0.2
-0.04
0.05
0.12
0.01
-0.21
0.04
-0.05
0.16
0.16
-0.1
-0.1
-0.1
.
-0.14
-0.15
0.01
0
0.24
PAK3
0.16
0.11
0.04
0.19
0.07
-0.13
-0.13
0.06
0.06
0.26
-0.25
0.1
0.2
-0.11
-0.2
.
0.23
0.2
0.05
0.17
0.16
0.13
NISCH
-0.06
-0.25
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
KIF1A
-0.07
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
AIM1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THYROID NORMAL + BENIGN PATHOLOGY
 
 
 
 
 
 
 
 
                                           

The diagonal row of boxes lists the markers analyzed; correlations are indicated at the horizontal and vertical intersections of the markers. Light gray shading represents R > 0.5; dark gray shading represents R > 0.7. The samples were split into two groups: correlation between the pair of genes in tumors (n = 44) indicated in the upper half of the plot and correlations between normal (benign pathology and normal thyroid tissue, n = 59) indicated in the lower half of the plot. Black asterisk (*) indicates similar correlations observed in both groups. Black dot (.) indicates that the correlation could not be calculated due to values being mainly zero.